Overview

Tirzepatide for the Treatment of Cannabis Use Disorder

Status:
NOT_YET_RECRUITING
Trial end date:
2028-06-30
Target enrollment:
Participant gender:
Summary
This is a pilot randomized cross-over trial to examine the effects of tirzepatide on cue-reactivity among individuals with cannabis use disorder.
Phase:
PHASE2
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Tirzepatide